ALKERMES | Capitalisation Boursière



Market Capitalization Changement Date
AbbVie USD 347.08B 19.2B 2025-08
Acadia Pharmaceuticals USD 4.09B 483M 2025-08
ALKERMES USD 4.3B 422M 2025-08
Amgen USD 154.93B 4.8B 2025-08
Biogen USD 19.23B 818M 2025-08
BioMarin Pharmaceutical USD 10.92B 378M 2025-08
Bristol-Myers Squibb USD 90.13B 4.07B 2025-08
Eli Lilly USD 615.07B 123.72B 2025-08
Gilead Sciences USD 147.49B 9.58B 2025-08
Ionis Pharmaceuticals USD 6.2B 94M 2025-08
J&J USD 366.71B 32.94B 2025-06
Merck USD 201.3B 2.52B 2025-08
Neurocrine Biosciences USD 12.83B 388M 2025-08
Otsuka Holdings JPY 4.1T 213.49B 2025-08
Pfizer USD 139.98B 2.45B 2025-08
Regeneron Pharmaceuticals USD 62.39B 6.52B 2025-08
Vertex Pharmaceuticals USD 97.9B 16.43B 2025-08


ALKERMES Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.